Using a high-throughput tissue microarray approach consisting of benign prostate hyperplasia and prostate cancer samples, we have validated that ING3 protein levels are elevated in prostate cancer, corresponding to cBioPortal genomic data [32]. Here, ING3 is linked to prostate carcinoma.